Episodes

Tuesday Jun 15, 2021
Tuesday Jun 15, 2021
In this episode, we chat with Dr. Vipin Garg, the President and CEO of Altimmune, a biotech company pioneering the development of intranasal vaccines and therapeutics, including ones that can prevent the transmission of and treat COVID.
He has more than three decades of experience in the biotechnology and pharmaceutical industries with a successful track record building and leading notable private and publicly traded companies.
Dr. Garg was named a Top 25 Biotech CEO of 2021 by The Healthcare Technology Report. He received his PhD in Biochemistry in 1982 from the University of Adelaide, Australia, and his Master of Science degree from IARI Nuclear Research.
We hope you enjoy the show.

Tuesday Jun 08, 2021
The Man Behind Mobile Engagement: CleverTap’s Sunil Thomas
Tuesday Jun 08, 2021
Tuesday Jun 08, 2021
In this episode, we speak with Sunil Thomas, the CEO and cofounder of CleverTap, which is the leading customer engagement and retention platform that helps brands maximize user lifetime value.
Consumer brands around the world representing over 8,000 apps—including Vodafone, Star, Sony, Discovery, Fandango LATAM, Carousell, and Gojek—trust CleverTap to help them improve user engagement and retention thereby growing long term revenue.
CleverTap is backed by leading venture capital firms including Sequoia India, Tiger Global Management, Accel, and Recruit Holdings, and operates out of San Francisco, Seattle, London, Singapore, and Mumbai.
We chat with Sunil about how CleverTap is helping companies optimize the mobile experience for its users as well as his experience building the company.
We hope you enjoy the show.

Tuesday Jun 01, 2021
Atop The Growth Equity World: Blackstone Growth’s Global Head Jon Korngold
Tuesday Jun 01, 2021
Tuesday Jun 01, 2021
When it comes to growth equity, Jon Korngold, Global Head of Blackstone Growth, is as good as it gets. Perhaps he can be considered one of the few who sets today’s bar in the asset class. His rapid rise began at Goldman Sachs and General Atlantic, but maybe it began even earlier, maybe it began with a piece of advice his father gave him when he was growing up.
Blackstone recently announced the final close of Blackstone Growth (BXG), its inaugural growth equity fund. BXG was oversubscribed and closed at its hard cap of $4.5 billion – with third-party capital commitments from a wide range of family offices, entrepreneurs, endowments, strategic institutional investors, pension funds, high-net-worth individuals, and other investors – making it the largest first-time growth equity private fund raised in history.
We cover a lot of ground in our conversation from Blackstone Growth’s approach to growth equity to its unique platform capabilities to the importance of ESG.
We hope you enjoy the show.

Tuesday May 25, 2021
Tuesday May 25, 2021
At over $100 million in annual recurring revenue, Amplitude has consistently scaled each year since its founding in 2012. The Company provides a product intelligence platform that enables businesses to optimize digital product innovation. It serves over 30,000 teams at companies like Walmart, Ford, Inbev, Atlassian, Microsoft, Twitter, Hubspot, and Procter & Gamble.
Amplitude’s cerebral yet highly attuned founder and CEO, Spenser Skates, is largely to thank for the company’s rapid rise. He is not only a highly skilled entrepreneur, he is a global thinker and proactive leader stepping up in areas for the betterment of society. We cover a wide range of topics spanning Spenser’s source of inspiration, his early beginnings as an entrepreneur and his disciplined approach to consistent scaling.
The company is backed by Benchmark, Battery, IVP, Sequoia and GIC.
We hope you enjoy the show.

Tuesday May 18, 2021
Europe’s Leading Software Investor: Hg’s Nic Humphries
Tuesday May 18, 2021
Tuesday May 18, 2021
I’ve spoken to hundreds of private equity investors over the years, and after spending time with Nic, you can’t help but come away feeling that he would make for a great capital partner. Nic Humphries is the Senior Partner and Executive Chairman of Hg and Head of the Saturn fund.
Hg, the leading european private equity firm focused on software and services, has over $30 billion under management and is supported by an investment team of over 140 people, plus a portfolio team of more than 35 operators. The firm is based in London, Munich and New York.
Nic has led or co-led more than 30 investments over the last 27 years. He started his investing career in 1990 and has focused exclusively on technology and software since 1994. He joined Hg in 2001 as founder of the firm’s Technology Team.
We hope you enjoy the show.

Tuesday May 11, 2021
Fast New Growth In Franchising: CEO Peter Holt of The Joint Chiropractic
Tuesday May 11, 2021
Tuesday May 11, 2021
In this episode, we chat with Peter Holt, the CEO of The Joint Chiropractic, the largest franchised network of Chiropractic clinics in the world with approximately 600 clinics system wide. The Joint is a publicly traded company on NASDAQ based in Scottsdale, AZ.
Previously, Peter was President and Chief Executive Officer for Tasti D-Lite where he transformed the NYC based licensed outlets into a complete business format franchise system..
He has been active in the franchise community for more than 30 years, helping iconic companies such as Mail Boxes Etc. (now The UPS Store), Tasti D Lite and Planet Smoothie manage their franchise systems in both domestic and overseas markets.
We hope you enjoy the show.

Tuesday Apr 27, 2021
Tuesday Apr 27, 2021
In this episode, we chat with Matthew Safaii, the Founder and Managing Partner of Arrowroot Capital Management, a growth equity firm based in Marina Del Ray, California. The firm invests in growing and healthy, recurring revenue, software-as-a-service and internet-based businesses. Recently, Matthew launched Arrowroot Acquisition, a $250 million SPAC which focuses on enterprise software.
Matthew was named a Top 25 Software Investor of 2020 by GrowthCap. He began his investing career at Platinum Equity and subsequently TA Associates in the Boston and London offices. He also served as a managing director and head of acquisitions at Actua. Matthew graduated from Boston College and holds an MBA from The Wharton School.
We hope you enjoy the show.

Tuesday Apr 13, 2021
Leading The Largest Care Provider in Europe: Cera CEO Dr. Ben Maruthappu
Tuesday Apr 13, 2021
Tuesday Apr 13, 2021
In this episode, we chat with Dr. Ben Maruthappu, the Co-Founder and CEO at Cera, which is a technology-enabled home care provider using digital and data to improve elderly care services. Cera was launched in November 2016 and since then has grown to over $160 million in revenues and is EBITDA positive.
The company now has 5,000+ employees, with 50 offices across the country, delivering ~30,000 care visits a day, making it the largest care company in Europe, if not beyond. It has raised approximately $100 million of financing.
Dr. Ben is highly accomplished in the business and medical fields with degrees from Oxford University, Harvard University and Cambridge University. He served as a Senior Advisor to Bain, Board Member of Imperial College Healthcare NHS Trust, and Operating Partner at Kairos, among other notable positions.
We hope you enjoy the show.

Tuesday Mar 30, 2021
A Top Biotech CEO in Cancer Treatments: F-star Therapeutics CEO Eliot Forster
Tuesday Mar 30, 2021
Tuesday Mar 30, 2021
Eliot Forster is the Chief Executive Officer of F-star Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing next-generation immunotherapies to transform the lives of patients with cancer. To date, the company has built a comprehensive IP estate, with over 200 issued patents and more than 60 pending applications, many of which have blockbuster potential.
In this conversation, we discuss Eliot’s career as a corporate executive in big pharma as well as his transition to and leadership experience in venture and growth stage biotech. Before coming to F-star in 2018, he served as chief executive officer of Immunocore and prior to that, he held executive positions at Creabilis Therapeutics, Solace Pharmaceuticals, and Pfizer.
We also explore the broader biotech industry in the context of private company investing as well as the specifics of F-star’s drug development programs.
We hope you enjoy the show

Monday Mar 15, 2021
Monday Mar 15, 2021
In this episode, we chat with Rami Karjian, Co-Founder and CEO of Medically Home, an innovative tech-enabled clinical enterprise that is transforming the way hospital care is given globally.
Rami began his career with McKinsey & Company where he worked for over 13 years across multiple offices and rose to Partner. Subsequently, he was the President of Flextronics, the largest global technology provider of post-manufacturing supply chain logistics and repair services.
Rami then went on to co-found Medically Home in 2016. To date, the company has raised over $60 million from strategic healthcare partners. It continues to succeed in bringing the virtual hospital to the homes of high and medium acuity patients with common medical diagnoses.
We hope you enjoy the show.